asessing the ptvg-hp plasmid dna vaccine in patients with mcrpc
Published 2 years ago • 112 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:05
combining a dna vaccine with pembrolizumab for mcrpc
-
2:10
evaluation of a dna vaccine for prostate cancer
-
57:00
mod-09 lec-34 dna vaccines
-
3:07
psma-trt, 225ac-j591 and 177lu-psma i&t in mcrpc
-
16:00
mrna vaccines & therapeutics manufacturing with dr. david loong, merck life science, singapore
-
1:00
#icushort 277: how to calculate the dose of ffp during plasmapheresis #esbicm
-
6:03
prostate-specific membrane antigen activated prodrug and imaging agents
-
1:32
combining antigen-specific vaccination and targeted radionuclide therapy in a murine prostate model
-
0:51
can a dna vaccine beat a shellfish allergy? | axa research fund
-
38:24
high-quality plasmid dna manufacturing strategies for gene and cell therapeutics webinar
-
0:23
dna vaccines elicit durable protective immunity against individual or simultaneous in... | rtcl.tv
-
5:25
developing vaccines as a treatment for prostate cancer
-
0:58
synthetic dna vaccines against prostate cancer
-
3:49
the role of targeting dna repair mutations in advanced prostate cancer
-
0:14
severe reaction to a nut allergy.
-
4:17
dna specimen provenance assay preventing overdiagnosis of prostate cancer
-
5:01
granulin-epithelin precursor and atp-dependent binding cassette (abc)b5 regulate liver cancer...
-
13:02
propresent® - the antigen presentation assay
-
16:04
large-scale production of plasmid dna & mrna to support therapeutic & vaccine development